A Plus Biotechnology Co

A Plus Biotechnology Co EBIT Margin

The EBIT Margin (Operating Margin) of A Plus Biotechnology Co (6918.TWO) as of Oct 17, 2026 is 23.71 %. In the previous year, EBIT Margin (Operating Margin) was 24.82 % — a change of -4.47% (lower).

EBIT Margin

23.71 %

YoY

-4.47%

Last updated:

EBIT Margin (Operating Margin) of A Plus Biotechnology Co is 2024 23.71 % . EBIT Margin (Operating Margin) of A Plus Biotechnology Co was 2023 24.82 % . It decreases by -4.47% lower compared to the previous year.

For A Plus Biotechnology Co, the operating (EBIT) margin of 23.7% is up versus 8.4% a few years ago.

The A Plus Biotechnology Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
8.81 TWD
Jan 1, 2020
8.45 TWD
Jan 1, 2021
8.63 TWD
Jan 1, 2022
10.88 TWD
Jan 1, 2023
24.82 TWD
Jan 1, 2024
23.71 TWD
The A Plus Biotechnology Co EBIT Margin history
YEAREBIT MarginYoY
23.71 %-4.47%
24.82 %+128.07%
10.88 %+26.15%
8.63 %+2.08%
8.45 %-4.07%
8.81 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

A Plus Biotechnology Co Stock analysis

What does A Plus Biotechnology Co do? A Plus Biotechnology Co Ltd, listed on the Taiwan Stock Exchange with ticker 6918.TWO, operates in the Health Care sector. The company is based in Taipei, Taiwan, and focuses on research, development, and manufacturing of orthopedic medical equipment. Its product portfolio includes trauma products for fracture fixation, orthopedic correction systems, artificial bone replacements, and spinal fixation devices. The company went public on January 6, 2023. Products are sold domestically and exported to mainland China, Asia, the United States, and Africa. A Plus Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about A Plus Biotechnology Co stock

EBIT Margin (Operating Margin) of A Plus Biotechnology Co is 23.71 % in 2024.

EBIT Margin (Operating Margin) of A Plus Biotechnology Co changed from 24.82 % to 23.71 %, representing a -4.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) A Plus Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s A Plus Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — A Plus Biotechnology Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — A Plus Biotechnology Co